Kerendia
Novo Nordisk acquires Corvidia Therapeutics for $1.3B to compete with Bayer’s Kerendia
Anika Sharma
Novo Nordisk, riding high on the success of its semaglutide sales, has taken a strategic leap by investing up to ...
Bayer launches new trials for Kerendia, a potential blockbuster for heart failure
Anika Sharma
Two summers ago, Bayer introduced Kerendia (finerenone) as a treatment for chronic kidney disease (CKD) linked to type 2 diabetes. ...
